Systemically administrered EGRFvIII-targeted bispecific antibody as an immunotherapeutic for glioblastoma.
Fellowship Grant
Administered By
Neurosurgery
Awarded By
National Institutes of Health
Start Date
March 1, 2015
End Date
February 28, 2019
Administered By
Neurosurgery
Awarded By
National Institutes of Health
Start Date
March 1, 2015
End Date
February 28, 2019